跳至主要内容
临床试验/DRKS00034342
DRKS00034342已完成不适用

The role of genetic polymorphisms in the CNS transport of endogenous metabolites and drugs in intensive care medicine. - CSFGENE

niversitätsmedizin Göttingen, Institut für klinische Pharmakologie0 个研究点目标入组 100 人开始时间: 2024年5月29日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • 1. Intensive care patients who have received an external cerebrospinal fluid drainage (EVD or LD) due to acute brain injury.
  • 2. Consent from the patient or their legal representative. If a legal representative is not available at the time of study inclusion, inclusion can be carried out under the assumption of presumed will due to the minimal risk and minimal burden of the study-related measures. As soon as the patient is responsive again or a guardian or healthcare proxy is available, they will be asked for consent. If consent is denied, the data and biomaterials of the affected patient will not be used further.

排除标准

  • 1. Exclusively palliative treatment due to a poor prognosis, expected survival < 48 hours.
  • 2. Refusal to participate in the study by the patient or by the guardian.
  • 3. Refusal of intensive medical care.

研究者

发起方
niversitätsmedizin Göttingen, Institut für klinische Pharmakologie

相似试验